CD81 and breast carcinoma: Indeed, Luga and colleagues demonstrated that EVs released from cancer-associated fibroblasts (CAFs) promote the increased motility and metastatic capability of breast cancer cells, which is dependent on the interaction of breast cancer cell-produced Wnt11 and CAF-derived CD81 [87].